Inflammatix
PrivateLast Round
Series E
Sep 12, 2024
Total Funding Raised
$209.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Inflammatix is a molecular diagnostics company that develops rapid tests to measure immune responses and assist healthcare providers in diagnosing acute infections and sepsis using advanced machine-learning algorithms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inflammatix Comparables
Compare Inflammatix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MeMed | 87% | |
| Cytovale | 86% | |
| Immunexpress | 79% | |
Inflammatix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 12, 2024 | ||||
| Grant | Nov 18, 2021 | ||||
| Series D | Mar 16, 2021 | ||||
| Series C | Jan 10, 2020 | ||||
| Grant | Nov 14, 2019 |
Key People
Founding team and executive leadership
Inflammatix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Think.Health | Series C, Series E, Series D |
| Grey Sky Venture Partners | Series C |
| Administration for Strategic Preparedness and Response | Grant |
| Khosla Ventures | Series D, Series C, Series E |
| Iberis Capital | Series E |
| OSF Ventures | Series D, Series E |
| Northpond Ventures | Series D, Series C, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 67% MoM, from 3.1K to 5.2K.
- Apr 26, 2026
Added Vhss1, a veterinary services startup, as a customer.
Inflammatix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inflammatix's valuation, stock price, and market status.